Dane Andreeff - Sep 12, 2022 Form 4 Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Signature
/s/ Dane Andreeff
Stock symbol
HSDT
Transactions as of
Sep 12, 2022
Transactions value $
$85,033
Form type
4
Date filed
9/14/2022, 04:38 PM
Previous filing
Aug 26, 2022
Next filing
Nov 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HSDT Common Stock Purchase $2.59K +4.75K +3.39% $0.54 145K Sep 12, 2022 See footnote F1
transaction HSDT Common Stock Purchase $552 +1.01K +3.31% $0.54 31.6K Sep 12, 2022 See footnote F2
transaction HSDT Common Stock Purchase $1.55K +2.84K +3.31% $0.54 88.6K Sep 12, 2022 See footnote F3
transaction HSDT Common Stock Purchase $144 +264 +3.47% $0.54 7.88K Sep 12, 2022 See footnote F4
transaction HSDT Common Stock Purchase $80.2K +150K +169.27% $0.53 239K Sep 13, 2022 See footnote F3
holding HSDT Common Stock 1.51K Sep 12, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSDT Stock Option (Right to Buy) Award $0 +86K $0.00 86K Sep 13, 2022 Common Stock 86K $0.54 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F2 The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities owned by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F3 The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F4 The shares are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F5 Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. The options vest in a series of twelve (12) successive equal quarterly installments on the last day of each quarter so that all of the options will be vested on the three-year anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting period.